SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: mmmary who wrote (8005)7/23/2001 4:26:01 PM
From: Kevin Podsiadlik  Read Replies (1) | Respond to of 19428
 
Herb Greenberg has a story on PLMD today. Seems that certain analysts were counting very heavily on the FBI investigation being terminated just in time for the NYSE listing.

Selected paragraphs from the article:

A little more than two weeks ago, First Union analyst Joel Ray said in morning notes to his firm that PolyMedica's CEO "indicated that within two weeks" the company "expects to receive a letter from the feds, which should put to bed the ... issues outstanding."

According to a tape recording sent to me and also allegedly to the FBI and the SEC, CIBC World Markets analyst John Calcagnini apparently was telling his firm's brokers a similar story a month ago. At least one money manager told me Calcagnini also told him independently that the FBI was issuing an apology to PolyMedica. Calcagnini told me he did not say that, but Mark (Martinez, another TSCM reporter) and I reviewed the tape, and it appears to be a recording of a voice mail message in which a CIBC broker told a client that Calcagnini was saying that "they're [PolyMedica] gonna see a press, uh, release with a favorable resolution in this government issue, um, within 30 days." According to the group that sent the tape -- which identified itself only as "concerned investors" -- the voice mail message was left more than 30 days ago.

A source familiar with the investigation says the FBI has not issued a letter of apology to PolyMedica.

And this note: Calcagnini reiterated his strong buy on PolyMedica Monday morning with a $70 price target.


Speaking of apologies, I wonder if Auric is ready to (heh heh) apologize for that AREM call yet.